Skip links and keyboard navigation

Hearing Monitoring Adult

Useful management information

No other information

Clinical resources

Ototoxic medications- impact long term codeine use

Minimum referral criteria (Does your patient meet the minimum criteria?)

Does your patient meet the minimum referral criteria?

Category 1
(appointment within 30 calendar days)

  • Referral for baseline hearing assessment prior to treatment for patients undergoing ototoxic treatment
  • Re-assessment/monitoring of hearing for those who are currently being treated with ototoxic agents
  • Suspected ototoxicity related to long term and/or GP prescribed medication
Category 2
(appointment within 90 calendar days)
  • Long term monitoring of ototoxic treatment (CF, haematology), over a long period of time
Category 3
(appointment within 365 calendar days)
  • No category 3 criteria

If your patient does not meet the minimum referral criteria

  • Assessment and management information can be found on a range of conditions at Brisbane South HealthPathways
  • If the patient does not meet the criteria for referral but the referring practitioner believes the patient requires specialist review, a clinical override may be requested:
    • Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
    • Please note that your referral may not be accepted or may be redirected to another service

Standard referral information (To be included in all referrals)


Patient's Demographic Details

  • Full name (including aliases)
  • Date of birth
  • Residential and postal address
  • Telephone contact number/s – home, mobile and alternative
  • Medicare number (where eligible)
  • Name of the parent or caregiver (if appropriate)
  • Preferred language and interpreter requirements
  • Identifies as Aboriginal and/or Torres Strait Islander

Referring Practitioner Details

  • Full name
  • Full address
  • Contact details – telephone, fax, email
  • Provider number
  • Date of referral
  • Signature

Relevant clinical information about the condition

  • Presenting symptoms (evolution and duration)
  • Physical findings
  • Details of previous treatment (including systemic and topical medications prescribed) including the course and outcome of the treatment
  • Body mass index (BMI)
  • Details of any associated medical conditions which may affect the condition or its treatment (e.g. diabetes), noting these must be stable and controlled prior to referral
  • Current medications and dosages
  • Drug allergies
  • Alcohol, tobacco and other drugs use

Reason for request

  • To establish a diagnosis
  • For treatment or intervention
  • For advice and management
  • For specialist to take over management
  • Reassurance for GP/second opinion
  • For a specified test/investigation the GP can't order, or the patient can't afford or access
  • Reassurance for the patient/family
  • For other reason (e.g. rapidly accelerating disease progression)
  • Clinical judgement indicates a referral for specialist review is necessary

Clinical modifiers

  • Impact on employment
  • Impact on education
  • Impact on home
  • Impact on activities of daily living
  • Impact on ability to care for others
  • Impact on personal frailty or safety
  • Identifies as Aboriginal and/or Torres Strait Islander

Other relevant information

  • Willingness to have surgery (where surgery is a likely intervention)
  • Choice to be treated as a public or private patient
  • Compensable status (e.g. DVA, Work Cover, Motor Vehicle Insurance, etc.)

Essential referral information for Hearing Monitoring Adult referrals (Referral will be returned without this)

  • Reason why hearing test needs to be monitored

Additional referral information for Hearing Monitoring Adult referrals

  • Details of current or previous treatments with ototoxic pharmaceutical agents:
    • Aminoglycoside and chemotherapeutic agents can cause permanent bilateral SNHL
    • Loop diuretics, salicylates, and antimalarial agents usually cause temporary bilateral SNHL that returns to normal soon after pharmacological therapy is stopped
  • Details of any change in hearing levels post commencement of pharmaceutical treatment if applicable
  • Details of any otologic symptoms or pre-existing hearing loss if applicable.
  • Any previous hearing assessments if applicable
  • ENT history if applicable
  • Neurology/neurosurgery history if applicable
  • Details of previous treatment (including systemic and topical medications prescribed) including the course and outcome of the treatment
  • Details of any trauma
  • Any previous audiology assessment results
  • The person's hearing and communication needs at home, at work or in education, and in social situations

Psychosocial difficulties related to hearing

Emergency

If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or seek emergent medical advice if in a remote region.

Hearing loss

  • Sudden loss or sudden deterioration of hearing (sudden = within 72 hours) (British Academy of Audiology, 2016)

Otitis media

  • Any suspicions of the complications of ASOM i.e. Mastoiditis (proptosis of pinna), meningitis etc

Vertigo/Vestibular

  • Recent sudden onset with neurological symptoms

Facial Nerve Palsy

  • Sudden onset facial weakness

Out of catchment

Metro South Health is responsible for providing public health services to the people who reside within its boundaries. Special consideration is made for patients requiring tertiary care or services that are not provided by their local Hospital and Health Service.  If your patient lives outside the Metro South Health area and you wish to refer them to one of our services, inclusion of information regarding their particular medical and social factors will assist with the triaging of your referral.

Last updated 14 December 2022